Status:

COMPLETED

Role of Pericapsular Nerve Block Using Dexmedetomidine and Bupivacaine in Improving the Outcome of Patients Undergoing Hip Surgery Under Spinal Anesthesia

Lead Sponsor:

Ain Shams University

Conditions:

Pain During Spinal Positioning

Eligibility:

All Genders

18-80 years

Phase:

PHASE1

Brief Summary

the investigators will compare the effectiveness and safety of the pericapsular nerve block (PENG) using dexmedetomidine and bupivacaine before giving spinal anesthesia in improving the quality and su...

Detailed Description

\- Pre-operative settings: Patients scheduled for Fracture Neck Femur surgery under spinal anesthesia will be thoroughly evaluated pre-operatively. A detailed medical history will be obtained, and all...

Eligibility Criteria

Inclusion

  • Patients aged ≥ 18 years, scheduled for elective fracture neck femur surgery, • Physical status: ASAI-III.

Exclusion

  • • Patients with contraindications to spinal anesthesia or regional blocks as:
  • significant coagulopathy
  • Known allergies to drugs used (Bupivacaine or dexmedetomidine)
  • Infection at site of injection
  • ASA IV
  • Cardiac patients with significant valve stenosis or sever pulmonary hypertension

Key Trial Info

Start Date :

December 10 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 10 2025

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT07149168

Start Date

December 10 2024

End Date

June 10 2025

Last Update

August 29 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ain Shams University

Cairo, Egypt, 11111